Despite a rise in share price, Shaanxi Kanghui Pharmaceutica...
Despite a rise in share price, Shaanxi Kanghui Pharmaceutical's P/S ratio lags behind others, possibly due to expectations of continued limited growth. A reversal in share price fortunes seems unlikely if trends persist.
Improved Revenues Required Before Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Stock's 33% Jump Looks Justified
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment